E-LIB Suche - Ergebnisse für: Borate, Uma

1

Toward a more patient‐centered drug development process in ..:

Efficace, Fabio ; Buckstein, Rena ; Abel, Gregory A....
HemaSphere. 8 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

2

Phase 2 study of add-on parsaclisib for patients with myelo..:

Yacoub, Abdulraheem ; Borate, Uma ; Rampal, Raajit K....
Blood Advances. 8 (2024) 6 - p. 1515-1528 , 2024

Link: https://doi.org/10.1182/..

3

Venetoclax plus azacitidine compared with intensive chemoth..:

Zeidan, Amer M. ; Pollyea, Daniel A. ; Borate, Uma...
Annals of Hematology. 102 (2023) 4 - p. 749-754 , 2023

Link: https://doi.org/10.1007/..

4

Correction to: Venetoclax plus azacitidine compared with in..:

Zeidan, Amer M. ; Pollyea, Daniel A. ; Borate, Uma...
Annals of Hematology. 102 (2023) 8 - p. 2299-2299 , 2023

Link: https://doi.org/10.1007/..

5

Entospletinib with decitabine in acute myeloid leukemia wit..:

Duong, Vu H. ; Ruppert, Amy S. ; Mims, Alice S....
Cancer. 129 (2023) 15 - p. 2308-2320 , 2023

Link: https://doi.org/10.1002/..

6

Real‐world genomic testing and treatment patterns of newly ..:

Byrd, John C. ; Gatz, Jennifer L. ; Louis, Cynthia Lim...
Cancer Medicine. 12 (2023) 17 - p. 18368-18380 , 2023

Link: https://doi.org/10.1002/..

7

P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETIN..:

Mims, Alice ; Huang, Ying ; Eisenmann, Eric...
HemaSphere. 7 (2023) S3 - p. e2938119 , 2023

Link: https://doi.org/10.1097/..

8

Current landscape of translational and clinical research in..:

Bewersdorf, Jan Philipp ; Xie, Zhuoer ; Bejar, Rafael...
Blood Reviews. 60 (2023) - p. 101072 , 2023

Link: https://doi.org/10.1016/..

9

Samples from patients with AML show high concordance in det..:

Borate, Uma ; Yang, Fei ; Press, Richard...
Blood Advances. 7 (2023) 20 - p. 6048-6054 , 2023

Link: https://doi.org/10.1182/..

10

Poster: MDS-476 Sabatolimab (MBG453) Combination Treatment ..:

Zeidan, Amer M. ; Al-Kali, Aref ; Borate, Uma...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S155 , 2022

Link: https://doi.org/10.1016/..

11

MDS-476 Sabatolimab (MBG453) Combination Treatment Regimens..:

Zeidan, Amer M. ; Al-Kali, Aref ; Borate, Uma...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S317 , 2022

Link: https://doi.org/10.1016/..

12

Poster: MPN-075 Efficacy and Safety of Add-on Parsaclisib t..:

Yacoub, Abdulraheem ; Borate, Uma ; Rampal, Raajit...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S156 , 2022

Link: https://doi.org/10.1016/..

13

Burden of chemotherapy in patients with relapsed/refractory..:

Pandya, Bhavik J. ; Chen, Chi-Chang ; McGuiness, Catherine B....
Expert Review of Hematology. 15 (2022) 9 - p. 857-866 , 2022

Link: https://doi.org/10.1080/..

14

Disabling Uncompetitive Inhibition of Oncogenic IDH Mutatio..:

Lyu, Junhua ; Liu, Yuxuan ; Gong, Lihu...
Cancer Discovery. 13 (2022) 1 - p. 170-193 , 2022

Link: https://doi.org/10.1158/..

15

A phase 1b study of venetoclax and azacitidine combination ..:

Zeidan, Amer M. ; Borate, Uma ; Pollyea, Daniel A....
American Journal of Hematology. 98 (2022) 2 - p. 272-281 , 2022

Link: https://doi.org/10.1002/..